Cognitive Dysfunction in Diabetes Mellitus

Diabetes mellitus is increasingly recognised as a risk factor for cognitive impairment, ranging from subtle decrements in processing speed and executive function to overt dementia. Chronic hyperglycaemia, insulin resistance and vascular dysfunction converge to produce microvascular injury, oxidative stress and neuroinflammation, which in turn disrupt synaptic integrity and neuronal viability. These pathological processes affect key structures such as the hippocampus and frontal cortex, leading to deficits in memory, attention and mental flexibility. Glycaemic variability and hypoglycaemic episodes further exacerbate neural injury, while coexisting cardiovascular and metabolic risk factors amplify cognitive vulnerability. Understanding the interplay between metabolic dysregulation and brain health is essential to inform screening strategies, individualise glycaemic targets and develop interventions aimed at preserving cognitive function in people with diabetes worldwide.

Research from Nature Portfolio

Recent studies have employed advanced machine learning approaches to identify distinct neuroanatomical patterns associated with type 2 diabetes. By analysing harmonised high-resolution MRI data from large multinational cohorts, these models reveal specific spatial signatures of cortical atrophy and white matter hyperintensities that correlate with glycaemic burden and cognitive performance. Such personalised biomarkers outperform conventional imaging metrics, detecting subclinical changes in mid-life individuals and demonstrating links with amyloid accumulation. The integration of metabolic and cardiovascular profiles into predictive frameworks offers a path towards early risk stratification and targeted prevention of diabetes-related cognitive decline.

Research from all publishers

A systematic review of microglial physiology under diabetic conditions highlights how persistent hyperglycaemia and insulin resistance modulate brain immune cells. Diabetes induces shifts in microglial phenotype, promoting pro-inflammatory cytokine release via pathways such as NF-κB and NLRP3 inflammasome, and fostering oxidative stress. These findings elucidate mechanisms by which metabolic dysregulation drives neurodegeneration. In parallel, neuroimaging studies using arterial spin labelling demonstrate that older adults with type 2 diabetes exhibit reduced cerebral blood flow in the hippocampus, inferior parietal and frontal regions. Lower perfusion in these areas is linked to poorer memory and executive function, suggesting that vascular deficits precede irreversible structural changes. Longitudinal cohort analyses further emphasise that longer disease duration and suboptimal glycaemic control in mid-life accelerate decline across memory, reasoning and fluency domains, underscoring the importance of early intervention and tight metabolic management to preserve cognition.

Cognitive Dysfunction in Diabetes Mellitus publication trend

The graph below shows the total number of articles in cognitive dysfunction in diabetes mellitus across all publications each year (not limited to Nature Index journals).

Technical terms

Hyperglycaemia: Elevated blood glucose levels causing endothelial and neuronal injury.

Glycaemic control: Regulation of blood glucose concentration to prevent metabolic complications.

Microglia: Resident immune cells in the brain that mediate neuroinflammatory responses.

Neuroinflammation: Activation of central immune pathways leading to cytokine release and tissue damage.

White matter hyperintensities: Areas of increased signal on MRI reflecting small-vessel disease.

Arterial spin labelling (ASL): MRI technique for non-invasive measurement of cerebral blood flow.

References

1. Machine learning reveals distinct neuroanatomical signatures of cardiovascular and metabolic diseases in cognitively unimpaired individuals. Nature Communications (2025).
2. Effects of diabetes on microglial physiology: a systematic review of in vitro, preclinical and clinical studies. Journal of Neuroinflammation (2023).
3. Diabetes and the Brain: Oxidative Stress, Inflammation, and Autophagy. Oxidative Medicine and Cellular Longevity (2014).
4. Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. The Lancet Diabetes & Endocrinology (2013).
5. Reduced Regional Cerebral Blood Flow Relates to Poorer Cognition in Older Adults With Type 2 Diabetes. Frontiers in Aging Neuroscience (2018).
6. Cognitive dysfunction in diabetes: how to implement emerging guidelines. Diabetologia (2019).